Mosapride (citrate)
Product Specifications
UNSPSC Description
Mosapride citrate is an orally active gastroenterokinetic compound. Mosapride citrate is a 5HT4 agonist. Mosapride citrate is a CYP inducer. Mosapride citrate has a concentration-dependent inhibitory effect on Kv4.3, and its IC50 value is 15.2 μM. Mosapride citrate can be used in the study of gastrointestinal diseases[1][2][3][4][5][6][7].
Target Antigen
5-HT Receptor; Cytochrome P450; Potassium Channel
Type
Reference compound
Related Pathways
GPCR/G Protein;Membrane Transporter/Ion Channel;Metabolic Enzyme/Protease;Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease; Cancer
Assay Protocol
https://www.medchemexpress.com/Mosapride-citrate.html
Purity
99.96
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(NCC1CN(CC2=CC=C(F)C=C2)CCO1)C3=CC(Cl)=C(N)C=C3OCC.O=C(CC(C(O)=O)(O)CC(O)=O)O
Molecular Weight
614.02
References & Citations
[1]Tack J, et al. Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther. 2012 Apr;35(7):745-67.|[2]Curran MP, et al. Mosapride in gastrointestinal disorders. Drugs. 2008;68(7):981-91.|[3]Kim HS, et al. The effect of mosapride citrate on proximal and distal colonic motor function in the guinea-pig in vitro. Neurogastroenterol Motil. 2008 Feb;20(2):169-76.|[4]Kim YH, et al. Measurement of Human Cytochrome P450 Enzyme Induction Based on Mesalazine and Mosapride Citrate Treatments Using a Luminescent Assay. Biomol Ther (Seoul). 2015 Sep;23(5):486-92.|[5]Uchida M, et al. Dual role of mosapride citrate hydrate on the gastric emptying evaluated by the breath test in conscious rats. J Pharmacol Sci. 2013;121(4):282-7.|[6]Fujisawa M, et al. The 5-HT4 receptor agonist mosapride attenuates NSAID-induced gastric mucosal damage. J Gastroenterol. 2010 Feb;45(2):179-86.|[7]Sung KW, et al. Effect of mosapride on Kv4.3 potassium channels expressed in CHO cells. Naunyn Schmiedebergs Arch Pharmacol. 2013 Oct;386(10):905-16.J Appl Microbiol. 2023 Jul 22;lxad153.|Chin J Integr Med. 2022 Aug 31.|Drug Metab Pharmacokinet. 2020 Feb;35(1):102-110.|J Ethnopharmacol. 2024 Apr 15:329:118118.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-B0189A/Mosapride-citrate-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-B0189A/Mosapride-citrate-SDS-MedChemExpress.pdf
Clinical Information
Launched
CAS Number
112885-42-4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1410338-01 0.02 mg (E-Coli)
Recombinant Escherichia coli O6:K15:H31 G/U mismatch-specific DNA glycosylase (mug)
Ask
View Details 
MBS1410338-02 0.1 mg (E-Coli)
Recombinant Escherichia coli O6:K15:H31 G/U mismatch-specific DNA glycosylase (mug)
Ask
View Details MBS1410338-03 0.02 mg (Yeast)
Recombinant Escherichia coli O6:K15:H31 G/U mismatch-specific DNA glycosylase (mug)
Ask
View Details 
MBS1410338-04 0.1 mg (Yeast)
Recombinant Escherichia coli O6:K15:H31 G/U mismatch-specific DNA glycosylase (mug)
Ask
View Details MBS1410338-05 0.02 mg (Baculovirus)
Recombinant Escherichia coli O6:K15:H31 G/U mismatch-specific DNA glycosylase (mug)
Ask
View Details MBS1410338-06 0.02 mg (Mammalian-Cell)
Recombinant Escherichia coli O6:K15:H31 G/U mismatch-specific DNA glycosylase (mug)
Ask
View Details